Hb. Ris et al., INTRAOPERATIVE PHOTODYNAMIC THERAPY WITH M-TETRAHYDROXYPHENYLCHLORIN FOR CHEST MALIGNANCIES, Lasers in surgery and medicine, 18(1), 1996, pp. 39-45
Background and Objective: Since there is no satisfactory treatment mod
ality for diffuse malignant mesothelioma of the chest, we assessed sur
gical tumor resection followed by intraoperative photodynamic therapy
with mTHPC in a phase I study. Study Design/Materials and Methods: Sin
ce 1990, eight patients have undergone intraoperative photodynamic the
rapy with m-tetrahydroxyphenylchlorin (mTHPC-PDT) following thoracotom
y and surgical tumor resection. Results: mTHPC-PDT-mediated tumor necr
osis was characterized by tumor infarction due to tumor vessel necrosi
s and thrombosis, and its extent depended on drug-light conditions; 65
0 nm light delivered at 0.1 W/cm(2) for 10 J/cm(2) 48 h after iv admin
istration of 0.3 mg mTHPC/kg resulted in a 10-mm-deep complete tumor n
ecrosis. Skin photosensitivity was related to the drug dose applied an
d occurred up to 17 days after iv administration of 0.3 mg mTHPC/kg, m
THPC-PDT of brachial plexus infiltrated by mesothelioma resulted in pa
in relief without deterioration of nerve function. Conclusion: Tumor r
esection and intraoperative mTHPC-PDT of the chest cavity is feasible
under clinical conditions and offers local tumor control of sites invo
lved. However, distant tumor spread was not prevented by this combined
treatment modality and optimization of mTHPC-PDT is warranted for fur
ther intraoperative application. (C) 1996 Wiley-Liss, Inc.